Will the COAPT study change treatment of mitral regurgitation?
This video is supported by Abbott
Summary
More effective, safer treatment is needed for functional mitral regurgitation (FMR), a consequence of myocardial disease and left ventricular disease, which is associated with poor quality of life and high mortality rates. Join Ralph Stephan von Bardeleben, Patrice Guerin and Saibal Kar as they examine the results of the COAPT study, which assessed transcatheter mitral valve approximation using the MitraClip. Find out how the study compares with the MITRA-FR study and what the future holds for treating FMR…
This interview supported by Abbott was filmed at EuroPCR 2019: see more videos here…